ATE397020T1 - Pharmazeutisch verwendbare stärke und deren herstellungsverfahren - Google Patents

Pharmazeutisch verwendbare stärke und deren herstellungsverfahren

Info

Publication number
ATE397020T1
ATE397020T1 AT01975101T AT01975101T ATE397020T1 AT E397020 T1 ATE397020 T1 AT E397020T1 AT 01975101 T AT01975101 T AT 01975101T AT 01975101 T AT01975101 T AT 01975101T AT E397020 T1 ATE397020 T1 AT E397020T1
Authority
AT
Austria
Prior art keywords
starch
production
pharmaceutically usable
purified
usable starch
Prior art date
Application number
AT01975101T
Other languages
English (en)
Inventor
Nils Gustafsson
Per Berden
Monica Joensson
Timo Laakso
Mats Reslow
Original Assignee
Pacira Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003616A external-priority patent/SE517422C2/sv
Application filed by Pacira Pharmaceuticals Inc filed Critical Pacira Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE397020T1 publication Critical patent/ATE397020T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/04—Extraction or purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01975101T 2000-10-06 2001-10-05 Pharmazeutisch verwendbare stärke und deren herstellungsverfahren ATE397020T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0003616A SE517422C2 (sv) 2000-10-06 2000-10-06 Farmaceutiskt acceptabel stärkelse
US26049101P 2001-01-08 2001-01-08

Publications (1)

Publication Number Publication Date
ATE397020T1 true ATE397020T1 (de) 2008-06-15

Family

ID=26655256

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01975098T ATE399182T1 (de) 2000-10-06 2001-10-05 Pharmazeutisch verwendbare stärke und deren herstellungsverfahren
AT01975101T ATE397020T1 (de) 2000-10-06 2001-10-05 Pharmazeutisch verwendbare stärke und deren herstellungsverfahren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01975098T ATE399182T1 (de) 2000-10-06 2001-10-05 Pharmazeutisch verwendbare stärke und deren herstellungsverfahren

Country Status (8)

Country Link
EP (2) EP1325034B1 (de)
JP (2) JP2004510845A (de)
AT (2) ATE399182T1 (de)
AU (2) AU2001294460A1 (de)
CA (2) CA2424931A1 (de)
DE (2) DE60134562D1 (de)
ES (1) ES2307650T3 (de)
WO (2) WO2002028908A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5100980B2 (ja) * 2005-05-18 2012-12-19 株式会社クラレ 化学物質の精製方法
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (de) 2005-05-27 2007-04-18 StratoSphere Pharma AB Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
CN114933661B (zh) * 2022-06-27 2022-12-20 上海交通大学 一种三偏磷酸钠交联淀粉的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279658A (en) * 1978-08-16 1981-07-21 Grain Processing Corporation Chemical-mechanical starch conversion
DE4132701A1 (de) * 1991-10-01 1993-04-08 Laevosan Gmbh & Co Kg Verfahren zur herstellung von staerkeabbauprodukten mit einer engen molekulargewichtsverteilung
DE4434877A1 (de) * 1994-09-29 1996-04-04 Fresenius Ag Verfahren zur Herstellung von Stärkeabbauprodukten
WO1999007743A1 (de) * 1997-08-08 1999-02-18 Fresenius Ag Verfahren zur kontinuierlichen herstellung von hydrolytish abgebauter ggfls. substituierter stärke, verwendung der hydrolytish abgebauten stärke und vorrichtung zu ihrer herstellung

Also Published As

Publication number Publication date
CA2424931A1 (en) 2002-04-11
EP1325035B1 (de) 2008-05-28
DE60134562D1 (de) 2008-08-07
ATE399182T1 (de) 2008-07-15
EP1325035A1 (de) 2003-07-09
DE60134249D1 (de) 2008-07-10
AU2001294457A1 (en) 2002-04-15
CA2424888A1 (en) 2002-04-11
EP1325034A1 (de) 2003-07-09
ES2307650T3 (es) 2008-12-01
AU2001294460A1 (en) 2002-04-15
JP2004510845A (ja) 2004-04-08
JP2004510846A (ja) 2004-04-08
EP1325034B1 (de) 2008-06-25
WO2002028908A1 (en) 2002-04-11
WO2002028909A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
ATE361847T1 (de) Strukturelement für eine fahrzeugradaufhängung und verfahren zu deren herstellung
MY122762A (en) Method for producing high-purity sulphuric acid
BR9917289B1 (pt) processo para produção de etanol a partir de cepas clostridium.
DE59502552D1 (de) Formkörper, enthaltend Silica-Aerogel-Partikel sowie Verfahren zu ihrer Herstellung
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
MY128168A (en) Method for producing high-purity hydrochloric acid.
EP0854508A3 (de) Herstellungsverfahren für eine Kontaktstruktur
MXPA04002052A (es) Tela para proceso industrial.
PL350135A1 (en) Process for purifying high molecular weight hyaluronic acid
ATE397020T1 (de) Pharmazeutisch verwendbare stärke und deren herstellungsverfahren
DE69808086D1 (de) Ein verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan-1,4,7-triessigsäure und deren derivaten
DE69803805D1 (de) Neues material und verfahren zu dessen herstellung
DE60026558D1 (de) Harzteilchen zum formen und verfahren zu deren herstellung
WO2002053598A3 (en) Manufacturing process for porous material
ITMI20000665A0 (it) Glicosaminoglicani derivati dal polisaccaride k5 aventi elevata attivita' anticoagulante ed antitrombotica e processo per la loro preparazio
TR200003302T2 (tr) Anti-astım, anti-alerjik, anti-enflamatuar, bağışıklık düzenleyici ve nöro-koruyucu etkiye sahip yeni 1,2,5-trisübstitüe edilmiş 1,2-dihidroindazol-3-onlar, bunların hazırlanması için işlem ve bunların ilaç olarak kullanımı.
ITVA20020023A1 (it) Prodotti per l'edilizia a base di idrossialchilguaro purificato
DE60136297D1 (de) Miniertem industrieverpackungsabfall
EP2003122A3 (de) Verfahren zur Herstellung der Verbindung 5-Hydroxy-1-Methylhydantoin
DE60127848D1 (de) T-butoxycarbonylaminoethylamine für die herstellung von pna-monomereinheiten, aminosäurederivate, zwischenprodukte und verfahren zu deren herstellung
DE10082578D2 (de) Verfahren zur Herstellung von regelmäßigen Nanostrukturen
ATE291569T1 (de) Verfahren zur herstellung von dnda
PL372217A1 (en) Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy)-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid
DE60001683D1 (de) Verfahren zur Reinigung von 3,7,11,15-Tetramethyl-2,4,6,10,14-hexadecapentaenonsäure
EP0478401A3 (de) Verfahren zur Herstellung von Nahrungsmittelfasern aus Karotten und durch dieses Verfahren erhaltene Fasern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties